Protein Kinase Cα (PKCα) Regulates P53 Localization and Melanoma Cell Survival Downstream of Integrin αv in Three-dimensional Collagen and in Vivo

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2012 Jul 10

PMID 22773839

Citations 13

Authors

Stephen D Smith

Martin Enge

Wenjie Bao

Minna Thullberg

Tania D F Costa

Helene Olofsson

Behxhet Gashi

Galina Selivanova

Staffan Stromblad

Affiliations

Soon will be listed here.

Abstract

Protein kinase C α (PKCα) is overexpressed in numerous types of cancer. Importantly, PKCα has been linked to metastasis of malignant melanoma in patients. However, it has been unclear how PKCα may be regulated and how it exerts its role in melanoma. Here, we identified a role for PKCα in melanoma cell survival in a three-dimensional collagen model mimicking the in vivo pathophysiology of the dermis. A pathway was identified that involved integrin αv-mediated up-regulation of PKCα and PKCα-dependent regulation of p53 localization, which was connected to melanoma cell survival. Melanoma survival and growth in three-dimensional microenvironments requires the expression of integrin αv, which acts to suppress p53 activity. Interestingly, microarray analysis revealed that PKCα was up-regulated by integrin αv in a three-dimensional microenvironment-dependent manner. Integrin αv was observed to promote a relocalization of endogenous p53 from the nucleus to the cytoplasm upon growth in three-dimensional collagen as well as in vivo, whereas stable knockdown of PKCα inhibited the integrin αv-mediated relocalization of p53. Importantly, knockdown of PKCα also promoted apoptosis in three-dimensional collagen and in vivo, resulting in reduced tumor growth. This indicates that PKCα constitutes a crucial component of the integrin αv-mediated pathway(s) that promote p53 relocalization and melanoma survival.

Citing Articles

PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner.

Zhang R, Liao W, Chen X, Wang J, Li J, Chen G Cell Death Dis. 2025; 16(1):19.

PMID: 39809736 PMC: 11733117. DOI: 10.1038/s41419-025-07341-5.

Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells.

Serrano-Lopez E, Coronado-Parra T, Marin-Vicente C, Szallasi Z, Gomez-Abellan V, Lopez-Andreo M Int J Mol Sci. 2022; 23(22).

PMID: 36430510 PMC: 9696894. DOI: 10.3390/ijms232214023.

Oestrogen Receptor Isoforms May Represent a Therapeutic Target in Oesophageal Adenocarcinoma.

Due S, Watson D, Bastian I, Eichelmann A, Hussey D Cancers (Basel). 2022; 14(8).

PMID: 35454796 PMC: 9032750. DOI: 10.3390/cancers14081891.

The complexities of PKCα signaling in cancer.

Black A, Black J Adv Biol Regul. 2020; 80:100769.

PMID: 33307285 PMC: 8141086. DOI: 10.1016/j.jbior.2020.100769.

The role of collagen in cancer: from bench to bedside.

Xu S, Xu H, Wang W, Li S, Li H, Li T J Transl Med. 2019; 17(1):309.

PMID: 31521169 PMC: 6744664. DOI: 10.1186/s12967-019-2058-1.

References

Haller D, Mackiewicz M, Gerber S, Beyer D, Kullmann B, Schneider I . Cytoplasmic sequestration of p53 promotes survival in leukocytes transformed by Theileria. Oncogene. 2010; 29(21):3079-86. DOI: 10.1038/onc.2010.61. View

Tsubaki M, Matsuoka H, Yamamoto C, Kato C, Ogaki M, Satou T . The protein kinase C inhibitor, H7, inhibits tumor cell invasion and metastasis in mouse melanoma via suppression of ERK1/2. Clin Exp Metastasis. 2007; 24(6):431-8. DOI: 10.1007/s10585-007-9080-z. View

Ruvolo P, Deng X, Carr B, May W . A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem. 1998; 273(39):25436-42. DOI: 10.1074/jbc.273.39.25436. View

Rucci N, DiGiacinto C, Orru L, Millimaggi D, Baron R, Teti A . A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells. J Cell Sci. 2005; 118(Pt 15):3263-75. DOI: 10.1242/jcs.02436. View

Dang C, Lee W . Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J Biol Chem. 1989; 264(30):18019-23. View

Youmell M, Park S, Basu S, Price B . Regulation of the p53 protein by protein kinase C alpha and protein kinase C zeta. Biochem Biophys Res Commun. 1998; 245(2):514-8. DOI: 10.1006/bbrc.1998.8471. View

Jorgensen K, Skrede M, Cruciani V, Mikalsen S, Slipicevic A, Florenes V . Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2. Biochem Biophys Res Commun. 2005; 329(1):266-74. DOI: 10.1016/j.bbrc.2005.01.143. View

Gutcher I, Webb P, Anderson N . The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci. 2003; 60(6):1061-70. PMC: 11138515. DOI: 10.1007/s00018-003-2281-y. View

Cameron A, Procyk K, Leitges M, Parker P . PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival. Int J Cancer. 2008; 123(4):769-79. DOI: 10.1002/ijc.23560. View

10.

Larsen M, Artym V, Green J, Yamada K . The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol. 2006; 18(5):463-71. DOI: 10.1016/j.ceb.2006.08.009. View

11.

Lahn M, Sundell K . The role of protein kinase C-alpha (PKC-alpha) in melanoma. Melanoma Res. 2004; 14(2):85-9. DOI: 10.1097/00008390-200404000-00002. View

12.

Luu Y, Li G . The p53-stabilizing compound, CP-31398, does not enhance chemosensitivity in human melanoma cells. Anticancer Res. 2003; 23(1A):99-105. View

13.

Bao W, Stromblad S . Integrin alphav-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen. J Cell Biol. 2004; 167(4):745-56. PMC: 2172581. DOI: 10.1083/jcb.200404018. View

14.

Cukierman E, Pankov R, Stevens D, Yamada K . Taking cell-matrix adhesions to the third dimension. Science. 2001; 294(5547):1708-12. DOI: 10.1126/science.1064829. View

15.

Brooks P, Montgomery A, Rosenfeld M, Reisfeld R, Hu T, Klier G . Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994; 79(7):1157-64. DOI: 10.1016/0092-8674(94)90007-8. View

16.

Felding-Habermann B, Mueller B, Romerdahl C, Cheresh D . Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. J Clin Invest. 1992; 89(6):2018-22. PMC: 295910. DOI: 10.1172/JCI115811. View

17.

Satyamoorthy K, Chehab N, Waterman M, LIEN M, El-Deiry W, Herlyn M . Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells. Cell Growth Differ. 2000; 11(9):467-74. View

18.

Jiffar T, Kurinna S, Suck G, Carlson-Bremer D, Ricciardi M, Konopleva M . PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation. Leukemia. 2004; 18(3):505-12. DOI: 10.1038/sj.leu.2403275. View

19.

Legate K, Montanez E, Kudlacek O, Fassler R . ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol. 2006; 7(1):20-31. DOI: 10.1038/nrm1789. View

20.

Delphin C, Huang K, Scotto C, Chapel A, Vincon M, Chambaz E . The in vitro phosphorylation of p53 by calcium-dependent protein kinase C--characterization of a protein-kinase-C-binding site on p53. Eur J Biochem. 1997; 245(3):684-92. DOI: 10.1111/j.1432-1033.1997.t01-1-00684.x. View